Browsing Tag
Sydney
68 posts
OncoSil Medical (ASX: OSL) rallies as FDA decision window opens
OncoSil is rallying into an FDA decision, but its trial was not designed to prove superiority. Can ASX turn clinical promise into sales?
Stakk (ASX:SKK) hits A$26m revenue run rate, but cash conversion must prove the rerating
Stakk has an A$26m revenue run rate and 85%+ margins. The test is whether ASX:SKK can convert major contracts into recurring cash.
HiTech Group bids up to A$15m for UpperGround as ASX:HIT trades near yearly low
HiTech Group Australia has submitted a conditional proposal for selected UpperGround assets and employees, potentially transforming its technology recruitment scale while introducing debt, dilution and integration risk.
Australia’s largest cocaine seizure uncovers 2.7 tonnes hidden beneath Sydney property
Australian police found 2.7 tonnes of cocaine hidden beneath a Sydney property, exposing an alleged maritime smuggling route from Queensland.
Commonwealth Bank splits technology leadership as ASX:CBA puts AI and resilience under CEO
Commonwealth Bank splits technology leadership as AI and cyber move closer to the CEO. Discover what ASX:CBA's change means for execution and valuation now.
Challenger merges Fidante into A$150bn Channel Group as ASX:CGF hits 52-week high
Challenger Limited is exchanging full control of Fidante for cash and a strategic stake in a larger funds-management platform, responding to active equity outflows without abandoning the sector.
Soul Patts unlocks A$1.9bn in Goodman property sale as ASX:SOL hits 52-week high
Washington H. Soul Pattinson is converting a mature industrial property investment into A$1.89 billion of deployable capital, placing greater pressure on management to find its next generation of returns.
Racura Oncology (ASX:RAC) funds three cancer trials, but can RC220 justify the valuation?
Racura Oncology has funded three RC220 trials, but valuation now depends on clinical proof. Can ASX:RAC turn capital into decisive cancer data?
Melbana Energy (ASX:MAY) faces Cuba sanctions shock, but Block 9 still holds the upside test
Melbana has Block 9 oil upside, but Cuba sanctions have changed the risk map. The next ASX:MAY update could reset the story.
BPH Energy (ASX:BPH) faces a court catalyst that could reset its small-cap risk story
BPH has a court date and a tiny market value. The real question is whether PEP-11 clarity can turn risk into a cleaner roadmap.